| mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.29 |
3e-07 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-07 |
| mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.28 |
4e-07 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-07 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-06 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-06 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
1e-06 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-06 |